L21- Human Diseases Caused by Viruses & Prions

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall with Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/33

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No study sessions yet.

34 Terms

1
New cards

Chickenpox overview


• Chickenpox (Varicella) is very contagious. Typically,
in children 2-7 years. Acquired via droplet
inhalation.
• Pre-vaccine effected about 4 million children
annually and killed up to 150.
• Symptoms: Small vesicles erupt on face and upper
body. Vesicles fill with pus. When they rupture,
they scab and often leave scars.

2
New cards

Chickenpox Viral Structure:

  • dsDNA varicella-zoster virus.

  • Contain 6 glycoproteins that function in viral attachment.

  • Attach to cells on the respiratory epithelial cells.

3
New cards

Chickenpox Incubation period

incubation for 10-23 days of
division in the body

4
New cards

Chickenpox Testing

Vesicles can be observed visually. Whole
blood ELISA Lab tests are required to confirm.

5
New cards

Chickenpox and shingles are the same virus


• Immunity: Individuals who recover are not completely
free of the virus. Dormant virus can still reside in the
dorsal root ganglia. In situations where the individual is
immunocompromised (age, cancer, HIV, transplants,
psychological stress) the virus is activated.


• Medication: Acyclovir can be taken to shorten the
outbreak. Shingles vaccine is typically administered to
people who are 60 + years of age.

6
New cards

Covid Structure Virus

  • Large enveloped +stranded RNA virus –

  • Coronaviridae. Spike proteins attached to envelope
    help with attachment to host ACE2 on the respiratory
    track.

  • 30,000 nucleotides, coding for enzymes (RdRp) and spike protein

7
New cards

7 Coronaviruses-

  • 4 cause common cold. 3 are more serious.

    • SARS-CoV – Epidemic in 2003 – 8000 cases, 774 dead.

    • MERS-CoV – Epidemic in 2012 – 2500 cases, 935 dead (34% mortality rate)

    • SARS-CoV2 – Pandemic 2019- 240 million cases, 4.9 million deaths (% can’t be calculated due to asymptomatic infections).

8
New cards
<p><span><span>Covid Genome</span></span></p>

Covid Genome

  • Less likely to undergo mutation to RdRp that has
    proofreading activity.

  • More cases, more replication, more mutations.

  • 79% homology to the original SARS-CoV.

  • 1st reservoir.

    • Horseshoe bates - 88% sequence homology to covid in humans

    • Civets – Wild cat. Intermediate host. Then jumped to humans.

9
New cards
<p><span><span>Covid Symptoms</span></span></p>

Covid Symptoms

  • Symptoms only seen in about 40% of the infected
    cases.

  • Two phases of symptoms.
    1. Clearing the virus- Symptoms start at ~day 4.
    Virus present in aerosols. Greatest viral load at
    the peak of symptoms. Fever, dry cough, loss of
    smell/taste, body aches, headaches.
    2. Dealing with inflammatory response. Only seem
    in some patients. After the infection clears,
    patient still can’t breathe and can’t oxygenate the
    body.

10
New cards
<p>Covid Testing/treatment</p>

Covid Testing/treatment

  • Most sensitive is RT-PCR testing.

    • Can detect even a single viroid.

  • Antigen testing in at-home tests. Not as
    sensitive.

  • Blood antibody tests can also be preformed.

    • The antibodies can last for several months
      after infection.

  • Antibodies can be extracted from 1
    person and administered to another
    individual to help with severe symptoms.

11
New cards

Covid Treatment


• No Cure.
• Vaccinate as many people as possible = herd immunity (90%).
• 2% of population with serious symptoms will overwhelm the hospital systems.

12
New cards

Influenza A and Influenza B cause the flu Overview

  • First case seen in 1580s and since then, 31 pandemics have been documented.

  • 1918- Spanish Flu, killed 50 million people. Other major flu pandemic are Asian flu. Hong Kong flu, Russian flu, Swine flu.

13
New cards

Influenza A and B symptoms

  • Fever, chills, runny nose, muscle aches, fatigue,
    headaches.

  • Virus is acquired by inhalation or ingestion.

14
New cards

Influenza A and Influenza B cause the flu: Structure

  • Negative strand RNA virus.

  • Family Orthomyxoviridae.

  • Three generas are Influenzavirus A, Influenzavirus B, Influenzavirus C.

  • Type A and B are human diseases

  • Has 2 envelope spikes hemagglutinin (HA) and
    neuraminidase (NA). HA binds to host, NA hydrolyzes the mucus on the epithelium cells and results in endocytosis of virus.

  • Viral classification based on their HA (HA1 – HA18) and NA (N1-N11). Different recombination’s form different subtypes.

  • Human form binds best to human tracheal epithelial calls

15
New cards

Influenza A and Influenza B cause the flu Mechanism

  • DNA: RNA sequence undergoes random mutations.

  • Depend on RNA dependent RNA polymerase to replicate their RNA genome which lacks proofreading activity.

  • Result in minor antigenic changes (antigenic drifts).

    • Antigenic drifts result in mismatch between virus and seasonal vaccine.

    • Mutations result in flu spike every 3-5 years.

  • Antigenic shift results in more significant changes in DNA sequence that are caused by the interaction of 2 different flu strains. This causes Pandemics. Often happens in China. The H5N1 and H7N9 are avian flu viruses that are most concerning to the CDC and WHO. They are closely monitored, and any positive cases are closely traced.

16
New cards

Influenza A and Influenza B Incubation Period

  • 1 – 2 days,

  • virus adheres to host respiratory epithelium.

  • Once in the cytoplasm, the HA functions in releasing virus from the nucleocapsid

17
New cards

Influenza A and Influenza B Treatment

  • Antiviral drugs such are

    • oseltamivir,

    • zanamivir,

    • peramivir

    • can reduce duration and severity of symptoms if taken within the first 48 hours.

    • These neuroaminidase inhibitors prevent the actions of neuroamindase and prevent detachment from host cells

18
New cards

Measles Background

  • Most contagious disease in the world.

  • Preventable, but still leading cause of death in young
    children globally. 134k deaths in 2015. Not an issue in the developed world but cases still arise in unvaccinated children in the U.S

19
New cards

Measles Structure

  • Negative strand, enveloped RNA virus.

  • Genus Morbillivirus.

  • The DNA encodes 8 proteins (6 structural). The
    viral hemagglutination glycoprotein attaches on the
    receptors on activated B, T, and Antigen-presenting cells.

  • Fuses with host cell and genetic material released in host cytosol.

  • Viral mRNA is capped and polyadenylated.

  • Virus is assembled on the host inner membrane.

20
New cards
<p>Measles Symptoms</p>

Measles Symptoms

  • Early symptoms include nasal discharge, cough, fever, headaches, conjunctivitis which lead to a rash consisting of red small bumps.

  • Rash lasts for about 7 days. Koplik’s spots are sometimes seen in the mouth. Early symptoms subside but more serious central nervous system degeneration result in permanent cognitive deficits and sometimes death.

21
New cards

Measles Incubation Period

  • 0 – 14 days incubation period. Symptoms begin
    after the 10th day

22
New cards
<p>Measles Treatment</p>

Measles Treatment

  • Treatment: No treatment is available.

  • MMR combination vaccine is available
    and recommended and provide
    lifelong immunity.
    Viral load = red
    Symptoms = black

23
New cards

Rubella (German Measles) Background

  • First Described in Germany in the 1800s. Very contagious and typically in children between the ages of 5-9 years old

24
New cards

Rubella (German Measles) Structure

  • Caused by the Rubella virus which is an enveloped,
    positive strand RNA virus. Member of the Togaviridae.

  • Transmitted in saliva and respiratory droplets

25
New cards

Rubella (German Measles) Incubation Period

  • The incubation period is between 12-23 days

26
New cards

Rubella (German Measles) Treatment

  • No treatment.

  • Vaccination as a preventive measure.

  • No rubella in the U.S. since 2009.

27
New cards
<p><span>Rubella (German Measles) Symptoms</span></p>

Rubella (German Measles) Symptoms

  • A rash of small spots. Typically lasting about 3 days. Accompanied by a fever.

  • Not such an issue for children but very
    serious if contracted by a pregnant female.
    Can lead to premature delivery, fetal death,
    damage to heart, eyes, ears, and brain
    (Congenital rubella syndrome).

28
New cards
<p>Acquired Immune Deficiency Syndrome (AIDS) Overview</p>

Acquired Immune Deficiency Syndrome (AIDS) Overview

  • Some viruses are not airborne and need close contact between individuals to allow for transmission.

  • Contact includes touching, kissing, sexual contact (semen increases HIV virulence by 100,000-fold), body fluids and secretions, open wounds.

  • One of the most devastating infections is acquires immune deficiency syndrome (AIDS).

  • By 2014, about 37 million people were infected. Less half those people were being treated with antiviral therapy. This is still an improvement from the numbers in 2010 where less than 25% were being treated.

  • The HIV virus can progress to AIDS if left untreated.

  • Left untreated, AIDS is fatal within 10 years post infection.

  • Anti-retroviral treatment can significantly
    reduce morbidity and mortality.

29
New cards

HIV structure

  • Positive-strand, enveloped RNA virus from the Retroviridae family. HIV-1 is dominant in the U.S. HIV 2 is dominant in Africa.

  • Virus contains the enzymes reverse
    transcriptase, integrase, as well as
    protease.

30
New cards
<p>Viral Attachment</p>

Viral Attachment

  • To infect host cell, the HIV viral gp120
    envelope protein binds to the CD4
    receptor + chemokine co-receptor (CCR5
    or CXCR-4) on T cells, macrophages, and
    dendritic cells. Dendritic cells are likely the
    first cells infected.

  • Attachment to host cell doesn’t occur if
    the individual has a homozygous mutation
    in their CCR5 co-receptor. Heterozygous
    individuals have altered presentation of
    the disease.

31
New cards

HIV viral Entry

  • The HIV virus enters the host cell by endocytosis or membrane fusion.

  • Endocytosis: The viral membrane is stripped in the vacuole

32
New cards
<p><span><span>HIV genome</span></span></p>

HIV genome

  • Once inside the cell, the RNA is used as a template to make a double- stranded DNA molecule using the reverse transcriptase.

  • The double stranded DNA (provirus) and the viral integrase make their way
    to the nucleus where integrase fuses the viral DNA into the cell’s DNA.

  • Provirus can remain latent for many years.

  • When active, the provirus can be transcribed into mRNA and translated into a long polypeptide. The polypeptide is cleaved into individual proteins using
    viral protease.

  • Proteins are used to assemble new virions.

  • Virions are released from host cell. Host cell dies in the process

33
New cards

AIDS Symptoms

  • Early symptoms of infection (2 to 4 weeks post infection): Rash, fever, malaise,
    headaches, rash, weight loss, enlarged lymph nodes.

    • Asymptomatic stage: Latent stage of viral infection can last as long as 10 years.

    • Chronic symptomatic stage: great multiplication of virus. CD4 cells decline,
      fever, weight loss, malaise, fatigue, anorexia, lymphadenopathy.

    • As CD4 cells continue to decline, secondary infections arise (oral candidiasis, TB,
      Mycobacterium avium, pneumonia, meningitis, cytomegalovirus, encephalitis,
      and many others). Viral infected macrophages can also cross the blood brain
      barrier which can lead to central nervous system effects (headaches, cognitive
      changes, reflexes, ataxia, severe sensory and motor changes)

34
New cards

AIDS Treatment

  • Antiviral treatments that target RT, Integrate, Replication, etc.

  • No vaccine currently available because the virus is
    constantly changing its antigenic properties.